Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Colorcon
Moodys
Baxter
Express Scripts
McKinsey
Johnson and Johnson

Last Updated: December 14, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020589

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

NDA 020589 describes CHILDREN'S ADVIL-FLAVORED, which is a drug marketed by Pfizer and is included in one NDA. It is available from one supplier. There is one patent protecting this drug. Additional details are available on the CHILDREN'S ADVIL-FLAVORED profile page.

The generic ingredient in CHILDREN'S ADVIL-FLAVORED is ibuprofen. There are sixty-four drug master file entries for this compound. Two hundred and fifty-five suppliers are listed for this compound. Additional details are available on the ibuprofen profile page.
Summary for 020589
Tradename:CHILDREN'S ADVIL-FLAVORED
Applicant:Pfizer
Ingredient:ibuprofen
Patents:1
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 020589
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CHILDREN'S ADVIL ibuprofen SUSPENSION;ORAL 020589 NDA Wyeth Consumer Healthcare LLC 0573-0170 0573-0170-01 1 BOTTLE in 1 CARTON (0573-0170-01) > 30 mL in 1 BOTTLE
CHILDREN'S ADVIL ibuprofen SUSPENSION;ORAL 020589 NDA Wyeth Consumer Healthcare LLC 0573-0170 0573-0170-30 1 BOTTLE in 1 CARTON (0573-0170-30) > 120 mL in 1 BOTTLE

Profile for product number 001

Active Rx/OTC/Discontinued:OTCDosage:SUSPENSION;ORALStrength100MG/5ML
Approval Date:Jun 27, 1996TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:OTCDosage:SUSPENSION;ORALStrength100MG/5ML
Approval Date:Nov 7, 1997TE:RLD:No
Patent:  Start TrialPatent Expiration:May 25, 2024Product Flag?YSubstance Flag?Delist Request?

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Colorcon
Johnson and Johnson
Express Scripts
McKinsey
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.